Multidisciplinary Genitourinary Oncology Course:

Transcription

1 Taussig Cancer Institute and Glickman Urological Institute present Multidisciplinary Genitourinary Oncology Course: Focus on Kidney, Bladder, and Testicular Cancer Thursday, December 14, 2017 Cleveland, OH

2 About the Course Urologic neoplasms represent the model for multidisciplinary management. With the rapid increase in our understanding of tumor biology and its extension into the clinic, there is an ever expanding therapeutic armamentarium available to manage patients with testicular, bladder, prostate and renal cell carcinoma. This one-day course is designed to provide a topical, clinically-based overview of many of the current therapy dilemmas faced by clinicians managing GU neoplasms, with an emphasis on the opportunities for multidisciplinary management. Urologists, medical oncologists, radiation oncologists, pathologists, nurses, physician assistants, and other health care providers with an interest in the management of patients with urologic malignancies should attend this course. Following participation in this course the participant will be able to: Integrate evolving knowledge of radiotherapy in the management of bladder and kidney cancer. Recognize the importance of the molecular biology of kidney and bladder cancers. Utilize evolving therapeutic options in patients with advanced kidney, bladder, and testicular cancers. Accreditation The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit. The Ohio Board of Nursing will accept at face value the number of contact hours awarded for an educational activity that has been approved for CE by a nationally accredited system of CE approval. Nurses are able to obtain CE that has been approved or provided by a nationally recognized accreditation system of continuing education. Examples include: The American Nurses Credentialing Center (ANCC) The Accreditation Council for Continuing Medical Education (ACCME) The International Association for Continuing Education and Training (IACET) Information For further information about this activity, contact Sheryl Krall at Local: Toll Free: x kralls2@ccf.org Deadline for Registration & Cancellation Register at The deadline for registration is 5:00 pm (PST), Tuesday, December 12, A request for refund must be received in writing by December 8, A $25 cancellation fee will be deducted after December 8, No refunds will be issued after December 14, For questions about registrations, please call or cmeregistration@ccf.org. Faculty Disclosure The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.

3 Faculty Course Co-Directors Jorge Garcia, MD GU Malignancy Program Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio Andrew Stephenson, MD Cleveland Clinic Glickman Urological Institute Cleveland, Ohio Guest Faculty Dean Bajorin, MD Memorial Sloan Kettering Cancer Center New York, NY Siamak Daneshmand, MD Institute of Urology Norris Comprehensive Cancer Center Los Angeles, CA David McDermott, MD Department of Hematology/ Oncology Dana Farber Cancer Center Boston, MA Robert Uzzo, MD Department of Surgical Oncology Fox Chase Cancer Center Philadelphia, PA Cleveland Clinic Faculty Ryan Berglund, MD Steven Campbell, MD, PhD Amr Fergany, MD Timothy Gilligan, MD Michael Gong, MD Petros Grivas, MD Georges-Pascal Haber, MD Byron Lee, MD Jesse McKenney, MD Department of Anatomic Pathology Omar Mian, MD, PhD Department of Translational Hematology and Oncology Research Location Cleveland, OH Phone: Moshe Ornstein, MD Christopher Przybycin, MD Department of Anatomic Pathology Brian Rini, MD Kevin Stephans, MD Department of Radiation Oncology Overnight Accommodations To make overnight reservations, please call the InterContinental Hotel at or toll free Directions From the South via I-77 or I-71: Take I-77 or I-71 North to downtown Cleveland. I-77 and I-71 merge with I-90 East. Follow I-90 East to Carnegie Avenue exit, turn right on Carnegie and proceed to East 100th Street garage. From the East via I-90: Follow I-90 west to Cleveland. Exit at Martin Luther King Blvd (MLK). Turn left onto MLK and proceed to East 105th Street. Turn right on East 105th Street and proceed to Carnegie Avenue. Turn right on Carnegie Avenue and drive to East 100th Street. Turn left onto East 100th Street to access the parking garage. From the West via I-90: Take I-90 to 490 to I-77 North merge with I-90 East. Exit at Carnegie Avenue. Turn right on Carnegie and proceed to East 100th Street garage. Parking is available in the visitor s garage on the corner of Carnegie Avenue and East 100th Street across from the hotel.

4 Program Multidisciplinary Genitourinary OncologyCourse: Focus on Kidney, Bladder, and Testicular Cancer December 14, :30 am Registration/Continental Breakfast 8:00 am Welcome/Introduction Jorge Garcia, MD and Andrew Stephenson, MD TESTICULAR and UROTHELIAL CANCER SESSION 8:05 am Role of Surgery in the Management of Low-stage and Advanced Germ Cell Tumor Siamak Daneshmand, MD 8:35 am Update in Systemic Management of Testis Cancer: Same Old Tricks? Timothy Gilligan, MD 9:05 am Case Presentations/Panel Discussion Moderators: Ryan Berglund, MD and Timothy Gilligan, MD Panel: Drs. Stephans, Daneshmand, McKenney, Bajorin 10:15 am Break 10:35 am Point-Counterpoint: Robotic Cystectomy and Intra-corporal Diversion is the New Standard for Invasive Bladder Cancer Pro: Georges-Pascal Haber, MD; Con: Siamak Daneshmand, MD 11:05 am Therapeutic Impact of Emerging Biology in TCC Dean Bajorin, MD 12:05 pm Lunch 1:00 pm Bladder Case Presentations/Panel Discussion Moderators: Byron Lee, MD and Timothy Gilligan, MD Panel: Drs. Mian, Gong, Daneshmand, McKenney, Grivas, Bajorin RENAL SESSION 2:00 pm Small Renal Masses: Has the Field Changed? Robert Uzzo, MD 2:30 pm Status of Adjuvant Therapy in High-risk RCC Moshe Ornstein, MD 3:00 pm Immunotherapy and Beyond David McDermott, MD 3:30 pm Case Presentations/Panel Discussion Moderators: Brian Rini, MD and Steven Campbell, MD, PhD Panel: Drs. Uzzo, Fergany, McDermott, Garcia, Ornstein, and Przybycin 4:30 pm Adjourn Time for questions and answers will be included in each presentation.

5 Registration Form Course # Multidisciplinary Genitourinary OncologyCourse: Focus on Kidney, Bladder, and Testicular Cancer Thursday, December 14, 2017 Cleveland, Ohio Fee includes registration materials, continental breakfast, breaks, and lunch. Registration Fees Physician: $150 Non-Physician: $50 Resident/Fellow*: $50 * Letter from program chairman or department chairman must accompany Resident/Fellow registration. To register online go to: CCF employees should check fees and register online at the above web address. If you would like to register using a credit card, please go to or call where it will be handled directly by a certified processor. Americans with Disabilities Act The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify Cleveland Clinic at at least two weeks prior to the activity.

6 Taussig Cancer Institute and Glickman Urological Institute present Multidisciplinary Genitourinary OncologyCourse: Focus on Kidney, Bladder, and Testicular Cancer Thursday, December 14, 2017 Cleveland, OH